{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T06:13:31Z","timestamp":1788329611345,"version":"build-2803163510"},"reference-count":110,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TRR 219"],"award-info":[{"award-number":["TRR 219"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["322900939"],"award-info":[{"award-number":["322900939"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TRR 219"],"award-info":[{"award-number":["TRR 219"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["322900939"],"award-info":[{"award-number":["322900939"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB 1739"],"award-info":[{"award-number":["SFB 1739"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["546544928]"],"award-info":[{"award-number":["546544928]"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1093\/eurheartj\/ehag606","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T11:32:18Z","timestamp":1784633538000},"source":"Crossref","is-referenced-by-count":0,"title":["Great debate: diabetic cardiomyopathy is a distinct disease"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1955-4199","authenticated-orcid":false,"given":"Petar","family":"Seferovic","sequence":"first","affiliation":[{"name":"Serbian Academy of Sciences and Arts and Faculty of Medicine , University Belgrade, Belgrade ,","place":["Serbia"]},{"name":"Faculty of Medicine, University of Belgrade , Belgrade ,","place":["Serbia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6141-634X","authenticated-orcid":false,"given":"Nikolaus","family":"Marx","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, RWTH Aachen University Hospital , Aachen ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9589-0023","authenticated-orcid":false,"given":"Marija","family":"Polovina","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Belgrade , Belgrade ,","place":["Serbia"]},{"name":"Department of Cardiology, University Clinical Centre of Serbia , Belgrade ,","place":["Serbia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5388-0270","authenticated-orcid":false,"given":"Stefano","family":"Del Prato","sequence":"additional","affiliation":[{"name":"Interdisciplinary Research Center \u2018Health Science\u2019, Sant'Anna School of Advanced Studies , Pisa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3197-3628","authenticated-orcid":false,"given":"Ovidiu","family":"Chioncel","sequence":"additional","affiliation":[{"name":"\u2018C.C. Iliescu\u2019 Institute of Cardiovascular Diseases , Bucharest ,","place":["Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9539-4804","authenticated-orcid":false,"given":"Paul","family":"Balfanz","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, RWTH Aachen University Hospital , Aachen ,","place":["Germany"]},{"name":"Department of Physiology, Henri Mondor Hospital, FHU-SENCODE, INSERM U955, Universit\u00e9 Paris-Est Cr\u00e9teil (UPEC), AP-HP , Cr\u00e9teil ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1471-1631","authenticated-orcid":false,"given":"Genevi\u00e8ve","family":"Derumeaux","sequence":"additional","affiliation":[{"name":"Department of Physiology, Henri Mondor Hospital, FHU-SENCODE, INSERM U955, Universit\u00e9 Paris-Est Cr\u00e9teil (UPEC), AP-HP , Cr\u00e9teil ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0162-5219","authenticated-orcid":false,"given":"Katharina","family":"Marx-Sch\u00fctt","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, RWTH Aachen University Hospital , Aachen ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9341-117X","authenticated-orcid":false,"given":"Johann","family":"Bauersachs","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Angiology, Hannover Medical School , Carl-Neuberg-Str. 1, Hannover 30625 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"key":"2026090201262775700_ehag606.001-B1","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","article-title":"ESC 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes","volume":"44","author":"Marx","year":"2023","journal-title":"Eur Heart J"},{"key":"2026090201262775700_ehag606.001-B2","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2026090201262775700_ehag606.001-B3","doi-asserted-by":"publisher","first-page":"4359","DOI":"10.1093\/eurheartj\/ehaf190","article-title":"2025 Focused Update of the 2019 ESC\/EAS Guidelines for the management of dyslipidaemias","volume":"46","author":"Mach","year":"2025","journal-title":"Eur Heart J"},{"key":"2026090201262775700_ehag606.001-B4","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1056\/NEJMoa2313917","article-title":"Semaglutide in patients with obesity-related heart failure and type 2 diabetes","volume":"390","author":"Kosiborod","year":"2024","journal-title":"N Engl J Med"},{"key":"2026090201262775700_ehag606.001-B5","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1056\/NEJMoa2410027","article-title":"Tirzepatide for heart failure with preserved ejection fraction and obesity","volume":"392","author":"Packer","year":"2025","journal-title":"N Engl J Med"},{"key":"2026090201262775700_ehag606.001-B6","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1093\/eurheartj\/ehaf057","article-title":"Near-universal prevalence of central adiposity in heart failure with preserved ejection fraction: the PARAGON-HF trial","volume":"46","author":"Peikert","year":"2025","journal-title":"Eur Heart J"},{"key":"2026090201262775700_ehag606.001-B7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/eurheartj\/ehaf645","article-title":"Do obesity and visceral adiposity promote heart failure with reduced ejection fraction?","volume":"47","author":"Packer","year":"2026","journal-title":"Eur Heart J"},{"key":"2026090201262775700_ehag606.001-B8","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1002\/ejhf.3347","article-title":"Diabetic myocardial disorder. A clinical consensus statement of the Heart Failure Association of the ESC and the ESC Working Group on Myocardial & Pericardial Diseases","volume":"26","author":"Seferovi\u0107","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"2026090201262775700_ehag606.001-B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2025.133554","article-title":"Diabetic cardiomyopathy revisited: the interplay between diabetes and heart failure","volume":"438","author":"Mann","year":"2025","journal-title":"Int J Cardiol"},{"key":"2026090201262775700_ehag606.001-B10","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1007\/s10741-025-10562-7","article-title":"Diabetic cardiomyopathy: mechanistic insights on molecular pathways and emerging therapeutic approaches","volume":"30","author":"Kaur","year":"2025","journal-title":"Heart Fail Rev"},{"key":"2026090201262775700_ehag606.001-B11","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC Guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur Heart J"},{"key":"2026090201262775700_ehag606.001-B12","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s00395-018-0711-0","article-title":"Of mice and men: models and mechanisms of diabetic cardiomyopathy","volume":"114","author":"Riehle","year":"2018","journal-title":"Basic Res Cardiol"},{"key":"2026090201262775700_ehag606.001-B13","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehag198","article-title":"From prescription to persistence: guideline-recommended medical therapy in HFrEF","author":"Bauersachs","year":"2026","journal-title":"Eur Heart J"},{"key":"2026090201262775700_ehag606.001-B14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(18)32590-X","article-title":"SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"393","author":"Zelniker","year":"2019","journal-title":"Lancet"},{"key":"2026090201262775700_ehag606.001-B15","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S2213-8587(17)30087-6","article-title":"Effect of sacubitril\/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial","volume":"5","author":"Seferovic","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026090201262775700_ehag606.002-B1","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1016\/j.jacc.2017.07.792","article-title":"Clinical implications of echocardiographic phenotypes of patients with diabetes mellitus","volume":"70","author":"Ernande","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026090201262775700_ehag606.002-B2","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/j.jacc.2021.08.020","article-title":"Prevalence and prognostic implications of diabetes with cardiomyopathy in community-dwelling adults","volume":"78","author":"Segar","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2026090201262775700_ehag606.002-B3","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1093\/eurheartj\/ehv134","article-title":"Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes","volume":"36","author":"Seferovi\u0107","year":"2015","journal-title":"Eur Heart J"},{"key":"2026090201262775700_ehag606.002-B4","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1002\/ejhf.3347","article-title":"Diabetic myocardial disorder. A clinical consensus statement of the Heart Failure Association of the ESC and the ESC Working Group on Myocardial & Pericardial Diseases","volume":"26","author":"Seferovi\u0107","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"2026090201262775700_ehag606.002-B5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jacc.2024.03.380","article-title":"Randomized trial of a selective aldose reductase inhibitor in patients with diabetic cardiomyopathy","volume":"84","author":"Januzzi","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026090201262775700_ehag606.002-B6","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1016\/j.jacc.2018.01.085","article-title":"SGLT-2 inhibitors and cardiovascular risk: an analysis of CVD-REAL","volume":"71","author":"Cavender","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026090201262775700_ehag606.002-B7","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jacc.2009.12.003","article-title":"The development of heart failure in patients with diabetes mellitus and pre-clinical diastolic dysfunction: a population-based study","volume":"55","author":"From","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026090201262775700_ehag606.002-B8","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1016\/j.jcmg.2018.03.015","article-title":"Diagnosis of nonischemic stage B heart failure in type 2 diabetes mellitus: optimal parameters for prediction of heart failure","volume":"11","author":"Wang","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026090201262775700_ehag606.002-B9","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1093\/ehjci\/jeaa070","article-title":"Incremental value of diastolic stress test in identifying subclinical heart failure in patients with diabetes mellitus","volume":"21","author":"Nishi","year":"2020","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026090201262775700_ehag606.002-B10","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1136\/heartjnl-2014-307391","article-title":"Subclinical LV dysfunction and 10-year outcomes in type 2 diabetes mellitus","volume":"101","author":"Holland","year":"2015","journal-title":"Heart"},{"key":"2026090201262775700_ehag606.002-B11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12933-016-0333-5","article-title":"Incremental prognostic value of global longitudinal strain in patients with type 2 diabetes mellitus","volume":"15","author":"Liu","year":"2016","journal-title":"Cardiovasc Diabetol"},{"key":"2026090201262775700_ehag606.002-B12","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.amjcard.2019.06.011","article-title":"Defining subclinical myocardial dysfunction and implications for patients with diabetes mellitus and preserved ejection fraction","volume":"124","author":"Ng","year":"2019","journal-title":"Am J Cardiol"},{"key":"2026090201262775700_ehag606.002-B13","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s12872-016-0395-z","article-title":"Silent diabetic cardiomyopathy in everyday practice: a clinical and echocardiographic study","volume":"16","author":"Loncarevic","year":"2016","journal-title":"BMC Cardiovasc Disord"},{"key":"2026090201262775700_ehag606.002-B14","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1093\/ejechocard\/jep097","article-title":"Subclinical left ventricular dysfunction in asymptomatic diabetic patients assessed by two-dimensional speckle tracking echocardiography: correlation with diabetic duration","volume":"10","author":"Nakai","year":"2009","journal-title":"Eur J Echocardiogr"},{"key":"2026090201262775700_ehag606.002-B15","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/743503","article-title":"Evidence for a specific diabetic cardiomyopathy: an observational retrospective echocardiographic study in 656 asymptomatic type 2 diabetic patients","volume":"2015","author":"Pham","year":"2015","journal-title":"Int J Endocrinol"},{"key":"2026090201262775700_ehag606.002-B16","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1038\/s41598-018-19229-w","article-title":"Increased left ventricular mass index is present in patients with type 2 diabetes without ischemic heart disease","volume":"8","author":"Seferovic","year":"2018","journal-title":"Sci Rep"},{"key":"2026090201262775700_ehag606.002-B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115843","article-title":"The current state of preclinical modeling of human diabetic cardiomyopathy using rodents","volume":"168","author":"Jasi\u0144ska-Stroschein","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"2026090201262775700_ehag606.002-B18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12933-018-0728-6","article-title":"Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007\u20132017","volume":"17","author":"Einarson","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"2026090201262775700_ehag606.002-B19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12933-024-02135-z","article-title":"Characterizing diabetic cardiomyopathy: baseline results from the ARISE-HF trial","volume":"23","author":"Januzzi","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"2026090201262775700_ehag606.002-B20","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1161\/CIRCIMAGING.123.015051","article-title":"Impact of diabetes on myocardial fibrosis in patients with hypertension: the REMODEL study","volume":"16","author":"Pua","year":"2023","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026090201262775700_ehag606.002-B21","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1161\/CIRCIMAGING.123.015732","article-title":"Early appearance of myocardial fibrosis in restrictive diabetic cardiomyopathy","volume":"16","author":"Paulus","year":"2023","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026090201262775700_ehag606.002-B22","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.jacasi.2024.08.016","article-title":"Myocardial abnormalities across the AHA\/ACC stages of heart failure in patients with diabetes","volume":"4","author":"Yang","year":"2024","journal-title":"JACC Asia"},{"key":"2026090201262775700_ehag606.002-B23","first-page":"110","article-title":"Endomyocardial biopsy in diabetic cardiomyopathy procedure, clinico-pathological & structural functional correlation","volume":"15","author":"Das","year":"1995","journal-title":"Int J Diab Dev Countries"},{"key":"2026090201262775700_ehag606.002-B24","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/j.1365-2559.1989.tb02200.x","article-title":"Endomyocardial biopsy pathology in insulin-dependent diabetic patients with abnormal ventricular function","volume":"14","author":"Sutherland","year":"1989","journal-title":"Histopathology"},{"key":"2026090201262775700_ehag606.002-B25","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/ejhf.2190","article-title":"Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position statement on endomyocardial biopsy","volume":"23","author":"Seferovi\u0107","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2026090201262775700_ehag606.002-B26","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.amjcard.2004.04.048","article-title":"Comparison of left ventricular function by tissue Doppler imaging in patients with diabetes mellitus without systemic hypertension versus diabetes mellitus with systemic hypertension","volume":"94","author":"Kosmala","year":"2004","journal-title":"Am J Cardiol"},{"key":"2026090201262775700_ehag606.002-B27","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12933-024-02136-y","article-title":"The double burden: type 1 diabetes and heart failure\u2014a comprehensive review","volume":"23","author":"Juli\u00e1n","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"2026090201262775700_ehag606.002-B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110805","article-title":"Type 1 diabetes and risk of heart failure: a systematic review and meta-analysis","volume":"202","author":"Haji","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"key":"2026090201262775700_ehag606.002-B29","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jchf.2020.10.013","article-title":"Biomarker-based risk prediction of incident heart failure in pre-diabetes and diabetes","volume":"9","author":"Pandey","year":"2021","journal-title":"JACC Heart Fail"},{"key":"2026090201262775700_ehag606.002-B30","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1161\/CIRCULATIONAHA.116.026807","article-title":"Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction","volume":"136","author":"Obokata","year":"2017","journal-title":"Circulation"},{"key":"2026090201262775700_ehag606.002-B31","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s12933-024-02378-w","article-title":"Relationship between NT-proBNP, echocardiographic abnormalities and functional status in patients with subclinical diabetic cardiomyopathy","volume":"23","author":"Gouda","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"2026090201262775700_ehag606.002-B32","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.123.011366","article-title":"Uncovering unrecognized heart failure with preserved ejection fraction among individuals with obesity and dyspnea","volume":"17","author":"Kosyakovsky","year":"2024","journal-title":"Circ Heart Fail"},{"key":"2026090201262775700_ehag606.002-B33","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","article-title":"2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes","volume":"44","author":"Marx","year":"2023","journal-title":"Eur Heart J"},{"key":"2026090201262775700_ehag606.002-B34","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1161\/CIRCULATIONAHA.122.063374","article-title":"Twenty years of cardiovascular complications and risk factors in patients with type 2 diabetes: a nationwide Swedish cohort study","volume":"147","author":"Sattar","year":"2023","journal-title":"Circulation"},{"key":"2026090201262775700_ehag606.002-B35","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1056\/NEJMoa2412006","article-title":"Intensive blood-pressure control in patients with type 2 diabetes","volume":"392","author":"Bi","year":"2025","journal-title":"N Engl J Med"},{"key":"2026090201262775700_ehag606.002-B36","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1001\/jama.2013.7588","article-title":"Natriuretic peptide\u2013based screening and collaborative care for heart failure: the STOP-HF randomized trial","volume":"310","author":"Ledwidge","year":"2013","journal-title":"JAMA"},{"key":"2026090201262775700_ehag606.002-B37","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.jacc.2013.05.069","article-title":"PONTIAC (NT-proBNP selected prevention of cardiac events in a population of diabetic patients without a history of cardiac disease): a prospective randomized controlled trial","volume":"62","author":"Huelsmann","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026090201262775700_ehag606.002-B38","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(18)32590-X","article-title":"SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"393","author":"Zelniker","year":"2019","journal-title":"Lancet"},{"key":"2026090201262775700_ehag606.002-B39","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/dom.13477","article-title":"Cardiovascular outcomes of sodium glucose cotransporter-2 inhibitors in patients with type 2 diabetes","volume":"21","author":"Dawwas","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"2026090201262775700_ehag606.002-B40","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1111\/dom.14474","article-title":"Comparative effectiveness and safety of sodium-glucose cotransporter-2 inhibitors versus metformin in patients with type 2 diabetes: an observational study using data from routine care","volume":"23","author":"Fralick","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"2026090201262775700_ehag606.002-B41","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.mayocp.2023.01.023","article-title":"SGLT2 inhibitors are associated with reduced cardiovascular disease in patients with type 2 diabetes: an analysis of real-world data","volume":"98","author":"Wang","year":"2023","journal-title":"Mayo Clin Proc"},{"key":"2026090201262775700_ehag606.002-B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2022.101418","article-title":"Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study","volume":"49","author":"Karasik","year":"2023","journal-title":"Diabetes Metab"},{"key":"2026090201262775700_ehag606.002-B43","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1093\/eurheartj\/ehaa419","article-title":"A randomized controlled trial of dapagliflozin on left ventricular hypertrophy in people with type two diabetes: the DAPA-LVH trial","volume":"41","author":"Brown","year":"2020","journal-title":"Eur Heart J"},{"key":"2026090201262775700_ehag606.002-B44","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1016\/j.jacc.2008.09.014","article-title":"The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis) study","volume":"52","author":"Bluemke","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026090201262775700_ehag606.002-B45","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1161\/hc3901.096700","article-title":"Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril","volume":"104","author":"Mathew","year":"2001","journal-title":"Circulation"},{"key":"2026090201262775700_ehag606.002-B46","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1056\/NEJMoa2313917","article-title":"Semaglutide in patients with obesity-related heart failure and type 2 diabetes","volume":"390","author":"Kosiborod","year":"2024","journal-title":"N Engl J Med"},{"key":"2026090201262775700_ehag606.002-B47","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1016\/j.jacc.2024.08.004","article-title":"Effects of semaglutide on heart failure outcomes in diabetes and chronic kidney disease in the FLOW trial","volume":"84","author":"Pratley","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026090201262775700_ehag606.002-B48","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1056\/NEJMoa2410027","article-title":"Tirzepatide for heart failure with preserved ejection fraction and obesity","volume":"392","author":"Packer","year":"2025","journal-title":"N Engl J Med"},{"key":"2026090201262775700_ehag606.002-B49","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m4573","article-title":"Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials","volume":"372","author":"Palmer","year":"2021","journal-title":"BMJ"},{"key":"2026090201262775700_ehag606.003-B1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0002-9149(74)90089-7","article-title":"Role of diabetes in congestive heart failure: the Framingham study","volume":"34","author":"Kannel","year":"1974","journal-title":"Am J Cardiol"},{"key":"2026090201262775700_ehag606.003-B2","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/ejhf.1138","article-title":"The innate immune system in chronic cardiomyopathy: a European Society of Cardiology (ESC) scientific statement from the Working Group on Myocardial Function of the ESC","volume":"20","author":"Frantz","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2026090201262775700_ehag606.003-B3","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/ejhf.1059","article-title":"An integrative translational approach to study heart failure with preserved ejection fraction: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology","volume":"20","author":"Louren\u00e7o","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2026090201262775700_ehag606.003-B4","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12933-017-0615-6","article-title":"Impact of empagliflozin on subclinical left ventricular dysfunctions and on the mechanisms involved in myocardial disease progression in type 2 diabetes: rationale and design of the EMPA-HEART trial","volume":"16","author":"Natali","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"2026090201262775700_ehag606.003-B5","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jacc.2009.12.003","article-title":"The development of heart failure in patients with diabetes mellitus and pre-clinical diastolic dysfunction a population-based study","volume":"55","author":"From","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026090201262775700_ehag606.003-B6","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1136\/heartjnl-2014-307391","article-title":"Subclinical LV dysfunction and 10-year outcomes in type 2 diabetes mellitus","volume":"101","author":"Holland","year":"2015","journal-title":"Heart"},{"key":"2026090201262775700_ehag606.003-B7","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jcmg.2016.02.033","article-title":"Association of insulin resistance and glycemic metabolic abnormalities with LV structure and function in middle age: the CARDIA study","volume":"10","author":"Kishi","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026090201262775700_ehag606.003-B8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021132","article-title":"Streptozotocin-induced type 1 and 2 diabetes mellitus mouse models show different functional, cellular and molecular patterns of diabetic cardiomyopathy","volume":"24","author":"Marino","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2026090201262775700_ehag606.003-B9","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1016\/j.jcmg.2018.03.015","article-title":"Diagnosis of nonischemic stage B heart failure in type 2 diabetes mellitus: optimal parameters for prediction of heart failure","volume":"11","author":"Wang","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026090201262775700_ehag606.003-B10","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jcmg.2024.03.001","article-title":"Noninvasive techniques for tracking biological aging of the cardiovascular system: JACC family series","volume":"17","author":"Raisi-Estabragh","year":"2024","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026090201262775700_ehag606.003-B11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12933-017-0506-x","article-title":"Diagnostic approaches for diabetic cardiomyopathy","volume":"16","author":"Lorenzo-Almor\u00f3s","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"2026090201262775700_ehag606.003-B12","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1093\/eurheartj\/ehv134","article-title":"Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes","volume":"36","author":"Seferovi\u0107","year":"2015","journal-title":"Eur Heart J"},{"key":"2026090201262775700_ehag606.003-B13","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1016\/j.jacc.2017.07.792","article-title":"Clinical implications of echocardiographic phenotypes of patients with diabetes mellitus","volume":"70","author":"Ernande","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026090201262775700_ehag606.003-B14","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.numecd.2009.09.005","article-title":"Implications of prevalent and incident diabetes mellitus on left ventricular geometry and function in the ageing heart: the MONICA\/KORA Augsburg cohort study","volume":"21","author":"Markus","year":"2011","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2026090201262775700_ehag606.003-B15","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1159\/000115189","article-title":"Hypertension and diabetes","volume":"45","author":"Grossman","year":"2008","journal-title":"Adv Cardiol"},{"key":"2026090201262775700_ehag606.003-B16","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1136\/hrt.2011.225482","article-title":"Systolic blood pressure and incident heart failure in the elderly. The Cardiovascular Health Study and the Health, Ageing and Body Composition Study","volume":"97","author":"Butler","year":"2011","journal-title":"Heart"},{"key":"2026090201262775700_ehag606.003-B17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11906-020-1017-9","article-title":"Pathophysiology of hypertensive heart disease: beyond left ventricular hypertrophy","volume":"22","author":"Nwabuo","year":"2020","journal-title":"Curr Hypertens Rep"},{"key":"2026090201262775700_ehag606.003-B18","doi-asserted-by":"publisher","first-page":"3794","DOI":"10.1093\/eurheartj\/ehac393","article-title":"Phenotyping the hypertensive heart","volume":"43","author":"Tadic","year":"2022","journal-title":"Eur Heart J"},{"key":"2026090201262775700_ehag606.003-B19","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.jcmg.2017.04.001","article-title":"Subclinical myocardial impairment in metabolic diseases","volume":"10","author":"Kosmala","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026090201262775700_ehag606.003-B20","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1161\/CIRCULATIONAHA.121.055830","article-title":"Diabetes status modifies the association between different measures of obesity and heart failure risk among older adults: a pooled analysis of community-based NHLBI cohorts","volume":"145","author":"Patel","year":"2022","journal-title":"Circulation"},{"key":"2026090201262775700_ehag606.003-B21","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nri2925","article-title":"Type 2 diabetes as an inflammatory disease","volume":"11","author":"Donath","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"2026090201262775700_ehag606.003-B22","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.720690","article-title":"Epicardial fat expansion in diabetic and obese patients with heart failure and preserved ejection fraction-a specific HFpEF phenotype","volume":"8","author":"Elsanhoury","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"2026090201262775700_ehag606.003-B23","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1210\/er.2015-1137","article-title":"Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus","volume":"37","author":"Kautzky-Willer","year":"2016","journal-title":"Endocr Rev"},{"key":"2026090201262775700_ehag606.003-B24","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1002\/ejhf.2534","article-title":"Distinct pathophysiological pathways in women and men with heart failure","volume":"24","author":"Ravera","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2026090201262775700_ehag606.003-B25","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.echo.2014.01.001","article-title":"Longitudinal myocardial strain alteration is associated with left ventricular remodeling in asymptomatic patients with type 2 diabetes mellitus","volume":"27","author":"Ernande","year":"2014","journal-title":"J Am Soc Echocardiogr"},{"key":"2026090201262775700_ehag606.003-B26","doi-asserted-by":"publisher","first-page":"e294","DOI":"10.1161\/CIR.0000000000000691","article-title":"Type 2 diabetes mellitus and heart failure: a scientific statement from the American Heart Association and the Heart Failure Society of America: this statement does not represent an update of the 2017 ACC\/AHA\/HFSA heart failure guideline update","volume":"140","author":"Dunlay","year":"2019","journal-title":"Circulation"},{"key":"2026090201262775700_ehag606.003-B27","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.cardfail.2014.02.007","article-title":"The prevalence of diabetic cardiomyopathy: a population-based study in Olmsted County, Minnesota","volume":"20","author":"Dandamudi","year":"2014","journal-title":"J Card Fail"},{"key":"2026090201262775700_ehag606.003-B28","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1016\/j.jacc.2022.03.378","article-title":"Diabetes and progression of heart failure: the Atherosclerosis Risk In Communities (ARIC) study","volume":"79","author":"Echouffo-Tcheugui","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2026090201262775700_ehag606.003-B29","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/j.jacc.2021.08.020","article-title":"Prevalence and prognostic implications of diabetes with cardiomyopathy in community-dwelling adults","volume":"78","author":"Segar","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2026090201262775700_ehag606.003-B30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41574-023-00898-1","article-title":"Inter-organ crosstalk during development and progression of type 2 diabetes mellitus","volume":"20","author":"Xourafa","year":"2024","journal-title":"Nat Rev Endocrinol"},{"key":"2026090201262775700_ehag606.003-B31","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1161\/CIRCRESAHA.125.325637","article-title":"Aging at the crossroads of organ interactions: implications for the heart","volume":"136","author":"Sen","year":"2025","journal-title":"Circ Res"},{"key":"2026090201262775700_ehag606.003-B32","doi-asserted-by":"publisher","first-page":"605","DOI":"10.4172\/2155-6156.1000605","article-title":"Diabetic cardiomyopathy: a new perspective of mechanistic approach","volume":"6","author":"Muralidaran","year":"2015","journal-title":"J Diabetes Metab"},{"key":"2026090201262775700_ehag606.003-B33","doi-asserted-by":"publisher","first-page":"685","DOI":"10.4239\/wjd.v12.i6.685","article-title":"Role of novel biomarkers in diabetic cardiomyopathy","volume":"12","author":"Kumric","year":"2021","journal-title":"World J Diabetes"},{"key":"2026090201262775700_ehag606.003-B34","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1161\/CIRCRESAHA.118.312706","article-title":"Established and emerging roles of biomarkers in heart failure","volume":"123","author":"Ibrahim","year":"2018","journal-title":"Circ Res"},{"key":"2026090201262775700_ehag606.003-B35","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.003048","article-title":"Novel biomarkers to improve the prediction of cardiovascular event risk in type 2 diabetes mellitus","volume":"5","author":"van der Leeuw","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"2026090201262775700_ehag606.003-B36","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1053\/euje.2000.0031","article-title":"Regional strain and strain rate measurements by cardiac ultrasound: principles, implementation and limitations","volume":"1","author":"D'Hooge","year":"2000","journal-title":"Eur J Echocardiogr"},{"key":"2026090201262775700_ehag606.003-B37","doi-asserted-by":"publisher","first-page":"e62","DOI":"10.1093\/ehjci\/jeab220","article-title":"Multimodality imaging approach to left ventricular dysfunction in diabetes: an expert consensus document from the European Association of Cardiovascular Imaging","volume":"23","author":"Marwick","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026090201262775700_ehag606.003-B38","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1007\/s10741-021-10195-6","article-title":"Imaging techniques for the assessment of adverse cardiac remodeling in metabolic syndrome","volume":"27","author":"Preda","year":"2022","journal-title":"Heart Fail Rev"},{"key":"2026090201262775700_ehag606.003-B39","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.jcmg.2020.05.036","article-title":"Imaging interstitial fibrosis, left ventricular remodeling, and function in stage A and B heart failure","volume":"14","author":"Pezel","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026090201262775700_ehag606.003-B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2025.107292","article-title":"Association of obesity subphenotypes with indices of cardiac remodeling in the Framingham heart study","volume":"292","author":"He","year":"2026","journal-title":"Am Heart J"},{"key":"2026090201262775700_ehag606.003-B41","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14144820","article-title":"Heterogeneity in heart failure with preserved ejection fraction: a systematic review of phenotypic classifications and clinical implications","volume":"14","author":"Epelde","year":"2025","journal-title":"J Clin Med"},{"key":"2026090201262775700_ehag606.003-B42","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1002\/ejhf.2169","article-title":"Identification of distinct phenotypic clusters in heart failure with preserved ejection fraction","volume":"23","author":"Uijl","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2026090201262775700_ehag606.003-B43","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1136\/heartjnl-2019-315481","article-title":"Identification of novel pheno-groups in heart failure with preserved ejection fraction using machine learning","volume":"106","author":"Hedman","year":"2020","journal-title":"Heart"},{"key":"2026090201262775700_ehag606.003-B44","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","article-title":"2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes","volume":"44","author":"Marx","year":"2023","journal-title":"Eur Heart J"},{"key":"2026090201262775700_ehag606.003-B45","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1016\/j.amjmed.2023.04.019","article-title":"Chapter 3: clinical trials of sodium-glucose co-transporter-2 inhibitors for treatment of heart failure","volume":"137","author":"Greene","year":"2024","journal-title":"Am J Med"},{"key":"2026090201262775700_ehag606.003-B46","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/advance-article-pdf\/doi\/10.1093\/eurheartj\/ehag606\/70903107\/ehag606.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/advance-article-pdf\/doi\/10.1093\/eurheartj\/ehag606\/70903107\/ehag606.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T05:26:38Z","timestamp":1788326798000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/advance-article\/doi\/10.1093\/eurheartj\/ehag606\/8779387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":110,"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehag606","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]},"article-number":"ehag606"}}